MC
VBIV

Moors & Cabot’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Moors & Cabot’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-333
Closed -$31K – 749
2020
Q2 		$31K Hold
333
– – ﹤0.01% 644
2020
Q1 		$10K Hold
333
– – ﹤0.01% 580
2019
Q4 		$14K Buy
+333
New +$7.29K ﹤0.01% 603

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Moors & Cabot's VBIV Position: Q3 2020 in Review

Moors & Cabot sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2020, closing a stake of 333 shares — an estimated $31K sold.

Moors & Cabot first reported a position in VBIV in Q4 2019 and held it in 3 quarters. The position peaked at $31K in Q2 2020. 114 funds tracked by Wall St. Rank hold VBIV as of Q3 2020.

  • Moors & Cabot reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2020 after selling out during the quarter.
  • Moors & Cabot sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2020, an estimated $31K.
  • Moors & Cabot first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 3 quarters.
  • Moors & Cabot's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $31K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2020.

Based on Moors & Cabot's 13F filing for Q3 2020, filed 9 Nov 2020.